Home Use of Mechanical Insufflation/Exsufflation Devices in Neuromuscular Diseases

Centre Hospitalier Universitaire Vaudois43 enrolled

Overview

With this cross-sectional study of adult subjects with neuromuscular disease in the French-speaking part of Switzerland, we aim to explore MI-E adherence using self-report questionnaires and device data in order to identify the factors that influence the pattern of MI-E use and satisfaction with the treatment. Determining potential barriers to regular long-term home use of MI-E could help in identifying the patients who would benefit most from this therapy.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Neuromuscular Diseases

Interventions

Mechanical insufflation/exsufflation device (MI-E)DEVICE

download of device (MI-E) data and self-reported satisfaction with the device

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age over 18 years * Diagnosis of neuromuscular disease * Active prescription of MI-E for more than 3 months Exclusion Criteria: -Invasive airway

Locations (1)

Service de Pneumologie, CHUV

Lausanne, Canton of Vaud, Switzerland

Outcomes

Primary Outcomes

Adherence to MI-E (reported)

based on self-reported use

Time frame: 12 months, or since treatment initiation (> 3 months)

Adherence to MI-E (objective)

based on data downloads

Time frame: 12 months, or since treatment initiation (> 3 months)

Secondary Outcomes

Satisfaction with the device

Self-report questionnaire

Time frame: 12 months, or since treatment initiation (> 3 months)

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.